CompletedNot Applicable

Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not

38 participantsStarted 2009-08-26

Plain-language summary

In this research prilocaine and botulinum toxin (BoNT-A) interventions prospectively compared to find out the effect of BoNT-A injection on myofascial pain syndrome (MPS). The main question it aims to answer is: Does Botulinum Toxin Type-A an Effective Way of Relieving Pain in Myofascial Pain Syndrome or not? For this purpose thirty-eight patients randomly assigned into two study groups. While BoNT-A injection group (BIG group n=19) treated with 20 units of toxin to each trigger point (TP), remaining treated with 2 ml prilocaine (PIG group n=19) with same procedure. Pre-treatment, 2nd and 6th weeks findings were clinically recorded.

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Age ≥ 20 years Presence of myofascial pain syndrome (MPS) symptoms for more than 3 months Ability and willingness to provide written informed consent Exclusion Criteria: Any injection to trigger points within the last 2 months Diagnosis of fibromyalgia syndrome Presence of significant respiratory or cardiovascular disease Presence of psychiatric disorders that may interfere with study participation History of shoulder or cervical spine intervention within the last year Presence of cervical myelopathy or cervical radiculopathy Inability to cooperate with study procedures or assessments

What they're measuring

Visual analog scale, 4-point verbal rating scale, Pressure pain threshold

Timeframe: Pre-treatment, 2nd and 6th week scores were recorded.

Trial details

NCT IDNCT06899438

SponsorBursa City Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2010-01-26